ASH 2019: Dr. Chaitra Ujjani on real world prescribing for chronic lymphocytic leukemia (CLL) and why expert care is critical At ASH 2019, Dr. Allan shared results from the first-in-human trial of vecabrutinib, a new drug which researchers hope will... March 30, 20202019 ConferencesBy Brad Hedrick
ASH 2019: Dr. John Allan on vecabrutinib for chronic lymphocytic leukemia (CLL) At ASH 2019, Dr. Allan shared results from the first-in-human trial of vecabrutinib, a new drug which researchers hope will... March 16, 20202019 ConferencesBy Brad Hedrick
ASH 2019: Dr. Mato Discusses a Novel Triple Therapy Clinical Trial for CLL/SLL, Richter’s Transformation and other Lymphomas In this interview, Dr. Mato discusses a Phase Ia/Ib Study Exploring the Synthetic Lethality of the Orally Administered Novel Bruton’s... March 9, 20202019 ConferencesBy Brad Hedrick
IWCLL 2019: Dr. Lamana Discusses the Appropriateness of Imaging in CLL (chronic lymphocytic leukemia) There is a role for imaging in managing CLL when there is an indication, but no role for “routine” imaging... March 2, 20202019 ConferencesBy Brad Hedrick
ASH 2019: Dr. Jennifer Brown on LOXO 305 for Chronic Lymphocytic Leukemia (CLL) We have so many great drugs to treat CLL. How to sequence them is unclear, but Dr. Mato presents some... February 24, 20202019 ConferencesBy Brad Hedrick
ASH 2019: Dr. Mato on Sequencing of Chronic Lymphocytic Leukemia (CLL) therapies after Venetoclax We have so many great drugs to treat CLL. How to sequence them is unclear, but Dr. Mato presents some... February 17, 20202019 ConferencesBy Brad Hedrick
iwCLL 2019: Dr. Parikh on chronic lymphocytic leukemia (CLL) flare after stopping ibrutinib treatment At iwCLL 2019, Dr. Kipps discusses how he approaches first CLL treatments with a heavy focus on fixed duration venetoclax... February 3, 20202019 ConferencesBy Brad Hedrick
iwCLL 2019: Dr. Thomas Kipps on Frontline Treatment in CLL (chronic lymphocytic leukemia) At iwCLL 2019, Dr. Kipps discusses how he approaches first CLL treatments with a heavy focus on fixed duration venetoclax... January 26, 20202019 ConferencesBy Brad Hedrick
ASH 2019: Dr. John Allan on Richter’s Transformation in CLL (chronic lymphocytic leukemia) Dr John Allan on new ways to target Richter’s Transformation.... January 19, 20202019 Conferences, Richter's TransformationBy Brad Hedrick
ASH 2019: Dr. Brian Koffman Interviewed by Zack Pemberton-Whiteley, Leukaemia Care, UK Our own Dr. Koffman was interviewed at ASH 2019 about importance of attending ASH for advocates, his own research, his... January 19, 20202019 ConferencesBy Brad Hedrick
